Combining iron chelators with the nucleoside analog didanosine in anti-HIV therapy.
Georgiou
N A
NA
Department of Internal Medicine, University Medical Center Utrecht, Heidelberglaan 100, F02.126, 3584 CX Utrecht, The Netherlands.
van der Bruggen
T
T
Oudshoorn
M
M
Nottet
H H
HH
Marx
J J
JJ
van Asbeck
B S
BS
D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016049:Didanosine / Q000494:pharmacology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D007502:Iron Chelating Agents / Q000494:pharmacology / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D007502:Iron Chelating Agents; D016049:Didanosine